Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy Figure S1 : Differential TMZ-sensitivity of glioma cells measured by G2-arrest. TMZ-sensitivity was evaluated in the primary MGMT unmethylated GB cell T269 as well as the GB cell lines T98G (unmethylated) and LN-Z308 (methylated) by G2-arrest with cell cycle analysis. MGMT is key resistance factor to TMZ treatment. MGMT-expressing T98G cells need TMZ at a dose of 200 μM to induce a G2-arrest of 5-6% while T269 and LN-Z308 cells need TMZ at 40 μM and 10 μM, respectively, to induce a comparable result.
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